Drug Trial Radar · NCT02793583
Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Last checked: Nov 20, 2026Latest source record: Jul 21, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
710
Actual
Start
May 25, 2016
Primary completion
May 31, 2022
Study completion Jul 4, 2022
Sponsor
- Lead sponsor
- TG Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 8, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Unity NHL - A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + Umbralisib with or without Bendamustine and Umbralisib alone in Patients with Previously Treated Non-Hodgkin's Lymphoma
Conditions
- Diffuse Large B-Cell Lymphoma
- Follicular Lymphoma
- Marginal Zone Lymphoma
- Mantle Cell Lymphoma
- Small Lymphocytic Lymphoma
Interventions
UblituximabBiological
UmbralisibDrug
BendamustineBiological
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Response RateTime frame: Every 8-12 weeks, up to 2 years
Locations
168 sites in 9 countries. Site status is shown where the registry gives one.
TG Therapeutics Investigational Trial Site
Birmingham, Alabama
TG Therapeutics Investigational Trial Site
Huntsville, Alabama
TG Therapeutics Investigational Trial Site
Chandler, Arizona
TG Therapeutics Investigational Trial Site
Tucson, Arizona
TG Therapeutics Investigational Trial Site
Tucson, Arizona
TG Therapeutics Investigational Trial Site
Los Angeles, California
TG Therapeutics Investigational Trial Site
Orange, California
TG Therapeutics Investigational Trial Site
San Diego, California
TG Therapeutics Investigational Trial Site
San Diego, California
TG Therapeutics Investigational Trial Site
Whittier, California
TG Therapeutics Investigational Trial Site
Aurora, Colorado
TG Therapeutics Investigational Trial Site
Denver, Colorado
TG Therapeutics Investigational Trial Site
Fort Collins, Colorado
TG Therapeutics Investigational Trial Site
Bridgeport, Connecticut
TG Therapeutics Investigational Trial Site
Newark, Delaware
TG Therapeutics Investigational Trial Site
Washington D.C., District of Columbia
TG Therapeutics Investigational Trial Site
Boca Raton, Florida
TG Therapeutics Investigational Trial Site
Fort Myers, Florida
TG Therapeutics Investigational Trial Site
Gainesville, Florida
TG Therapeutics Investigational Trial Site
Jacksonville, Florida
TG Therapeutics Investigational Trial Site
Jacksonville, Florida
TG Therapeutics Investigational Trial Site
Jacksonville, Florida
TG Therapeutics Investigational Trial Site
Miami, Florida
TG Therapeutics Investigational Trial Site
St. Petersburg, Florida
TG Therapeutics Investigational Trial Site
Tallahassee, Florida
TG Therapeutics Investigational Trial Site
Tampa, Florida
TG Therapeutics Investigational Trial Site
West Palm Beach, Florida
TG Therapeutics Investigational Trial Site
Albany, Georgia
TG Therapeutics Investigational Trial Site
Macon, Georgia
TG Therapeutics Investigational Trial Site
Marietta, Georgia
TG Therapeutics Investigational Trial Site
Chicago, Illinois
TG Therapeutics Investigational Trial Site
Chicago, Illinois
TG Therapeutics Investigational Trial Site
Decatur, Illinois
TG Therapeutics Investigational Trial Site
Evanston, Illinois
TG Therapeutics Investigational Trial Site
Harvey, Illinois
TG Therapeutics Investigational Trial Site
Maywood, Illinois
TG Therapeutics Investigational Trial Site
Niles, Illinois
TG Therapeutics Investigational Trial Site
Peoria, Illinois
TG Therapeutics Investigational Trial Site
Swansea, Illinois
TG Therapeutics Investigational Trial Site
Fort Wayne, Indiana
Showing 40 of 168 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.